MARY BABEHIS: Open Payments
NPI 1447945787 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,490 in 126 payments from 18 companies in 2025. Trend: 2023 $2,001 · 2024 $2,159 · 2025 $3,490
Food & beverage: $3,435Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 17 | $556 |
| JAZZ PHARMACEUTICALS INC. | 13 | $487 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $422 |
| Vanda Pharmaceuticals Inc. | 15 | $376 |
| ABBVIE INC. | 10 | $375 |
| Otsuka America Pharmaceutical, Inc. | 12 | $268 |
| Axsome Therapeutics, Inc. | 6 | $150 |
| Lundbeck LLC | 7 | $142 |
| E.R. Squibb & Sons, L.L.C. | 5 | $120 |
| Neurocrine BioSciences, Inc. | 4 | $107 |
Products named: XYWAV, SPRAVATO, CAPLYTA, FANAPT, VRAYLAR, ABILIFY ASIMTUFII, REXULTI, COBENFY.
Industry payments across IL — which companies pay providers there.
